It will be the number of samples they manufacture for future patients and their doctors. Nothing wins doctors over like proof in the pudding. After this your post and the street will have zero effect. Let's see who's laughing in the fall.
The issue, which has been in a major downtrend since peaking on February 10 at $7.88, has reached a new low for the recent decline at $4.31, surpassing the former low of the move of $4.50. This marks the lowest level for the issue since it bottomed at $3.80 in March 2014.
Hedge fund manager Martin Shkreli is exerting additional downside pressure on the issue. He has taken to Twitter to announce his plans to cover his short at , even though he believes their equity is "worthless."
This article is laughable. As to shkreli is now a joke since starting his own failed bio company. So short that jokers.
Hence the slow rollout. Sanofi is just using the Danbury plant to assign a figure to afrezza. But when they max out production. There will be other looking to buy afrezza. But sanofi still has the right of first refusa to beat any other suitors. So make hay while your sun shines short. You silver cloud has deep dark lining coming.
So, short rant until then. You will end up in the poor house. When shares fall to 2.00. You still will not be able to buy back 100 million shares. Just keep doubling down. I'm waiting!
Post post post! It won't matter by August or November at the latest. If not Alfred Mann will be dead of old age before they close the deal. He is living on borrowed time.
Reason he has no intention of manufacturing afrezza to the world. He will sell it to sanofi who can. The next two quarter will only assign afrezza's worth on the buyout by sanofi, with major public rollout. Nothing sells unless cokes know of it. So far the only ones who know are investors. When diabetics here of it they will buy it. How many shares have al picked up thru a third party? The allows him to accumulate without reporting. Plus he needs to buy back his shorted shares.
6 weeks of 12 weeks that make a quarter. Is no indication of afrezza's value. Second there has been no public rollout of a serious ad campaign. So gloat for now shorts. Please maintain your positions please. I like al would like to double my position at 2.00 a share thanks in whole to manipulators with al Mann's blessings. So please proceed!
Are fools. Second sale mean nothing when mankind's money will come from the sale of its drug and not the current deal to market afrezza. But manipulator twist it to get you to sell your shares. The question you should ask is why?
The Street Has Pounded Afrezza from Day One. Why Would They Change Now. Their Only Hurting Diabetics Who Read It!
if Your Long Just Take a Nap Until August Or November. Conciser The Danbury Plat Can't Service But A Few Hundred Thousand Diabetics. Sanofi Plant Could Service All. So, Hence The Slow Roll out. I Hope Cramer Doesn't Change His Opinion. Then All Can See The Fraud He Is. If You Need Confirmation Speak To A Real Diabetic That Has Used Afrezza.
Then I Will Double My Position. You Will Never Lose Buying Stock Compared To Going Broke Over Night Playing With Options. The Future Is Already Set. Analyst Have No Clue. Their Sources Are Out Dated And They Are To Lazy To Do Their Jobs. But Have No Fear, Afrezza Is The Real Deal. It Only Requires Proof To The Blind. On That Day I Hope Your Not Short. But Enjoy the Summer. Winter Always Kills.
Just Two Things Will. First Sales. Then A Buyout With Zero Forewarning. But You Will Need To Wait Until August Or November at The Latest. Sanofi Will Not Put Together A Major Ad Campaign Until Their Lines To Manufacture Toujeo And Afrezza As A Combined Product To Treat Diabetics And Stop Insulins Current Organ Causing Damage. Together They Will Save Insurance Companies Billions At The Hospital. So Shorts Are In Control Until They Aren't. So Just Watch The Grass Grow While We Wait. No, Lip Service Will Move Mankind Share's. Been Here Since 2009 And I Can Wait For The Latter Event To Occur. I Only Use The Past As A Guide And Diabetics I Personally Know.
Today They Have Only A Verbal Deal. Do You Really Think Danbury Will Be More Than A R&D Plant? Sanofi Is Working On Their Own Production Plant. They Will Ink The Deal In August Or November. Not Before. Diagnosed:21.0 million people.
Undiagnosed:8.1 million people (27.8% of people with diabetes are undiagnosed). In The Us Alone. That's Just Afrezza.Drugs That Can Benefit From Technospheres Have No Calculations Or Quantity Yet. So Until Mankind And Sanofi Have A Written Contract. Quit Guessing. Between the us, EU and Japan I Put The Deal North Of 45 Billion Dollars. Main Reason No Generics Will Not Touch Afrezza Or Any Other Drug That Utilizes Technospheres.
Then The Buyout Will Become Clear.
Notice They Run The Share price Down On Up Days? It's Their Last Measure Of Attack. But Still Longs Aren't selling. The Hedge Fund Manager Must Be Out Of His Mind. Wait For For 2.00. We Have Until august Or November. Then You Should On The Run Over 50.00 A Share Don't Hold then.